• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2100047 注射用重组人凝血因子Ⅸ Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2021-02-19 Pfizer Europe Ma Eeig;Wyeth Farma SA In Review 2021-02-18 view
JYSB2100046 注射用重组人凝血因子Ⅸ Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2021-02-19 Pfizer Europe Ma Eeig;Wyeth Farma SA In Review 2021-02-18 view
JYSB2100045 注射用重组人凝血因子Ⅸ Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2021-02-19 Pfizer Europe Ma Eeig;Wyeth Farma SA In Review 2021-02-18 view
JYSB2100048 注射用重组人凝血因子Ⅸ Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2021-02-19 Pfizer Europe Ma Eeig;Wyeth Farma SA In Review 2021-02-18 view
JYSB2000398 注射用重组人凝血因子IX Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2020-08-21 Pfizer Europe Ma Eeig;Wyeth Farma SA Filed 2020-09-15 view
JYSB2000397 注射用重组人凝血因子IX Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2020-08-21 Pfizer Europe Ma Eeig;Wyeth Farma SA Filed 2020-09-15 view
JYSB2000400 注射用重组人凝血因子IX Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2020-08-21 Pfizer Europe Ma Eeig;Wyeth Farma SA Filed 2020-09-15 view
JYSB2000399 注射用重组人凝血因子IX Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2020-08-21 Pfizer Europe Ma Eeig;Wyeth Farma SA Filed 2020-09-15 view
JYSB2000371 注射用重组人凝血因子Ⅸ Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2020-08-10 Pfizer Europe Ma Eeig;Wyeth Farma SA Filed 2020-08-19 view
JYSB2000374 注射用重组人凝血因子Ⅸ Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2020-08-10 Pfizer Europe Ma Eeig;Wyeth Farma SA Filed 2020-08-19 view
JYSB2000373 注射用重组人凝血因子Ⅸ Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2020-08-10 Pfizer Europe Ma Eeig;Wyeth Farma SA Filed 2020-08-19 view
JYSB2000372 注射用重组人凝血因子Ⅸ Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2020-08-10 Pfizer Europe Ma Eeig;Wyeth Farma SA Filed 2020-08-19 view
JYSB1800271 注射用重组人凝血因子Ⅸ Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2018-12-03 Pfizer Ltd Certificate Issued 2019-12-20 view
JYSB1800270 注射用重组人凝血因子Ⅸ Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2018-12-03 Pfizer Ltd Certificate Issued 2019-12-20 view
JYSB1800273 注射用重组人凝血因子Ⅸ Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2018-12-03 Pfizer Ltd Certificate Issued 2019-12-20 view
JYSB1800272 注射用重组人凝血因子Ⅸ Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2018-12-03 Pfizer Ltd Certificate Issued 2019-12-20 view
JYSB1900077 注射用重组人凝血因子Ⅸ Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2019-04-26 Wyeth Farma SA;Pfizer Ltd Certificate Issued 2019-10-30 view
JYSB1900076 注射用重组人凝血因子Ⅸ Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2019-04-26 Wyeth Farma SA;Pfizer Ltd Certificate Issued 2019-10-30 view
JYSB1900075 注射用重组人凝血因子Ⅸ Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2019-04-26 Wyeth Farma SA;Pfizer Ltd Certificate Issued 2019-10-30 view
JYSB1900078 注射用重组人凝血因子Ⅸ Recombinant Coagulation Factor Ⅸ Lyophilized Biological Products Supplementary Application 2019-04-26 Wyeth Farma SA;Pfizer Ltd Certificate Issued 2019-10-30 view